BELLEROPHON THERAPEUTICS has a total of 12 patent applications. Its first patent ever was published in 2019. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets medical technology and pharmaceuticals are TANAKA DON, SUZHOU LINHUA MEDICAL DEVICE CO LTD and SAFE T LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | Taiwan | 2 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Syringes | |
#2 | Diagnosis and surgery | |
#3 | Medical preparations | |
#4 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Shah Parag | 11 |
#2 | Dekker Martin | 6 |
#3 | Quinn Deborah | 4 |
#4 | Leonard William | 4 |
#5 | Zuzevicius Donatas | 4 |
#6 | Kim Bobae | 3 |
#7 | Fernandes Peter | 2 |
#8 | Fernandes Peter Paul | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020150195A1 | Combination drug therapies of pde-5 inhibitors and inhaled nitric oxide | |
WO2020142658A1 | Use of inhaled nitric oxide (ino) for improving activity levels in patients with lung-related conditions | |
TW202021637A | Use of inhaled nitric oxide (ino) for the improvement of severe hypoxemia | |
AU2019271408A1 | Method and apparatus for pulsatile delivery of nitric oxide |